A carregar...
Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
Polyglutamine (polyQ) diseases are a group of inherited neurodegenerative disorders caused by the expansion of the cytosine-adenine-guanine (CAG) repeat. This mutation encodes extended glutamine (Q) tract in the disease protein, resulting in the alteration of its conformation/physiological role and...
Na minha lista:
| Publicado no: | Front Cell Neurosci |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7573388/ https://ncbi.nlm.nih.gov/pubmed/33132851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2020.584277 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|